Bustos-Garcia, B.; Garza-Manero, S.; Cano-Dominguez, N.; Lopez-Sanchez, D.M.; Salgado-Montes de Oca, G.; Salgado-Aguayo, A.; Recillas-Targa, F.; Avila-Rios, S.; Valdes, V.J.
Development and Testing of a Low-Cost Inactivation Buffer That Allows for Direct SARS-CoV-2 Detection in Saliva. Vaccines 2022, 10, 730.
https://doi.org/10.3390/vaccines10050730
AMA Style
Bustos-Garcia B, Garza-Manero S, Cano-Dominguez N, Lopez-Sanchez DM, Salgado-Montes de Oca G, Salgado-Aguayo A, Recillas-Targa F, Avila-Rios S, Valdes VJ.
Development and Testing of a Low-Cost Inactivation Buffer That Allows for Direct SARS-CoV-2 Detection in Saliva. Vaccines. 2022; 10(5):730.
https://doi.org/10.3390/vaccines10050730
Chicago/Turabian Style
Bustos-Garcia, Brandon, Sylvia Garza-Manero, Nallely Cano-Dominguez, Dulce Maria Lopez-Sanchez, Gonzalo Salgado-Montes de Oca, Alfonso Salgado-Aguayo, Felix Recillas-Targa, Santiago Avila-Rios, and Victor Julian Valdes.
2022. "Development and Testing of a Low-Cost Inactivation Buffer That Allows for Direct SARS-CoV-2 Detection in Saliva" Vaccines 10, no. 5: 730.
https://doi.org/10.3390/vaccines10050730
APA Style
Bustos-Garcia, B., Garza-Manero, S., Cano-Dominguez, N., Lopez-Sanchez, D. M., Salgado-Montes de Oca, G., Salgado-Aguayo, A., Recillas-Targa, F., Avila-Rios, S., & Valdes, V. J.
(2022). Development and Testing of a Low-Cost Inactivation Buffer That Allows for Direct SARS-CoV-2 Detection in Saliva. Vaccines, 10(5), 730.
https://doi.org/10.3390/vaccines10050730
